Literature DB >> 34934948

Prevalence of Venovenous Shunting and High-Output State Quantified with 4D Flow MRI in Patients with Fontan Circulation.

Francesca Raimondi1, Duarte Martins1, Raluca Coenen1, Elena Panaioli1, Diala Khraiche1, Nathalie Boddaert1, Damien Bonnet1, Melany Atkins1, Howaida El-Said1, Laith Alshawabkeh1, Albert Hsiao1.   

Abstract

PURPOSE: To assess the ability of four-dimensional (4D) flow MRI to quantify flow volume of the Fontan circuit, including the frequency and hemodynamic contribution of systemic-to-pulmonary venovenous collateral vessels.
MATERIALS AND METHODS: In this retrospective study, patients with Fontan circulation were included from three institutions (2017-2021). Flow measurements were performed at several locations along the circuit by two readers, and collateral shunt volumes were quantified. The frequency of venovenous collaterals and structural defects were tabulated from concurrent MR angiography, contemporaneous CT, or catheter angiography and related to Fontan clinical status. Statistical analysis included Pearson and Spearman correlation and Bland-Altman analysis.
RESULTS: Seventy-five patients (mean age, 20 years; range, 5-58 years; 46 female and 29 male patients) were included. Interobserver agreement was high for aortic output, pulmonary arteries, pulmonary veins, superior vena cava (Glenn shunt), and inferior vena cava (Fontan conduit) (range, ρ = 0.913-0.975). Calculated shunt volume also showed strong agreement, on the basis of the difference between aortic and pulmonary flow (ρ = 0.935). A total of 37 of 75 (49%) of the patients exhibited shunts exceeding 1.00 L/min, 81% (30 of 37) of whom had pulmonary venous or atrial flow volume step-ups and corresponding venovenous collaterals. A total of 12% of patients (nine of 75) exhibited a high-output state (>4 L/min/m2), most of whom had venovenous shunts exceeding 30% of cardiac output.
CONCLUSION: Fontan flow and venovenous shunting can be reliably quantified at 4D flow MRI; high-output states were found in a higher proportion of patients than expected, among whom venovenous collaterals were common and constituted a substantial proportion of cardiac output.Keywords: Pediatrics, MR Angiography, Cardiac, Technology Assessment, Hemodynamics/Flow Dynamics, Congenital Supplemental material is available for this article. © RSNA, 2021. 2021 by the Radiological Society of North America, Inc.

Entities:  

Keywords:  Cardiac; Congenital; Hemodynamics/Flow Dynamics; MR Angiography; Pediatrics; Technology Assessment

Year:  2021        PMID: 34934948      PMCID: PMC8686005          DOI: 10.1148/ryct.210161

Source DB:  PubMed          Journal:  Radiol Cardiothorac Imaging        ISSN: 2638-6135


  31 in total

1.  Incidence and impact of systemic venous collateral development after Glenn and Fontan procedures.

Authors:  M Heinemann; J Breuer; V Steger; E Steil; L Sieverding; G Ziemer
Journal:  Thorac Cardiovasc Surg       Date:  2001-06       Impact factor: 1.827

2.  4D flow cardiac magnetic resonance in children and adults with congenital heart disease: Clinical experience in a high volume center.

Authors:  Marc-Antoine Isorni; Louis Moisson; Nidal Ben Moussa; Sébastien Monnot; Francesca Raimondi; Régine Roussin; Angèle Boet; Isabelle van Aerschot; Emmanuelle Fournier; Sarah Cohen; Meriem Kara; Sébastien Hascoet
Journal:  Int J Cardiol       Date:  2020-07-24       Impact factor: 4.164

3.  An optimal radial profile order based on the Golden Ratio for time-resolved MRI.

Authors:  Stefanie Winkelmann; Tobias Schaeffter; Thomas Koehler; Holger Eggers; Olaf Doessel
Journal:  IEEE Trans Med Imaging       Date:  2007-01       Impact factor: 10.048

4.  MRI Evaluation of Lymphatic Abnormalities in the Neck and Thorax after Fontan Surgery: Relationship with Outcome.

Authors:  David M Biko; Aaron G DeWitt; Erin M Pinto; Rodney E Morrison; Jordan A Johnstone; Heather Griffis; Michael L O'Byrne; Mark A Fogel; Matthew A Harris; Sara L Partington; Kevin K Whitehead; David Saul; David J Goldberg; Jack Rychik; Andrew C Glatz; Matthew J Gillespie; Jonathan J Rome; Yoav Dori
Journal:  Radiology       Date:  2019-04-02       Impact factor: 11.105

5.  Time-resolved three-dimensional magnetic resonance velocity mapping of cardiovascular flow paths in volunteers and patients with Fontan circulation.

Authors:  Michael Markl; Julia Geiger; Philip J Kilner; Daniela Föll; Brigitte Stiller; Friedhelm Beyersdorf; Raoul Arnold; Alex Frydrychowicz
Journal:  Eur J Cardiothorac Surg       Date:  2010-07-02       Impact factor: 4.191

6.  Fontan venovenous collaterals and hepatic fibrosis.

Authors:  William N Evans; Ruben J Acherman; Gary A Mayman; Alvaro Galindo; Abraham Rothman; Michael L Ciccolo; Juan Lehoux; Brody J Winn; Noel S Yumiaco; Humberto Restrepo
Journal:  J Card Surg       Date:  2020-08-13       Impact factor: 1.620

7.  Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operation.

Authors:  Rahul H Rathod; Ashwin Prakash; Andrew J Powell; Tal Geva
Journal:  J Am Coll Cardiol       Date:  2010-04-20       Impact factor: 24.094

8.  Free-breathing pediatric MRI with nonrigid motion correction and acceleration.

Authors:  Joseph Y Cheng; Tao Zhang; Nichanan Ruangwattanapaisarn; Marcus T Alley; Martin Uecker; John M Pauly; Michael Lustig; Shreyas S Vasanawala
Journal:  J Magn Reson Imaging       Date:  2014-10-20       Impact factor: 4.813

9.  Noninvasive quantification of systemic-to-pulmonary collateral flow: a major source of inefficiency in patients with superior cavopulmonary connections.

Authors:  Kevin K Whitehead; Matthew J Gillespie; Matthew A Harris; Mark A Fogel; Jonathan J Rome
Journal:  Circ Cardiovasc Imaging       Date:  2009-07-08       Impact factor: 7.792

10.  4D Flow Vorticity Visualization Predicts Regions of Quantitative Flow Inconsistency for Optimal Blood Flow Measurement.

Authors:  Francisco J Contijoch; Michael Horowitz; Evan Masutani; Seth Kligerman; Albert Hsiao
Journal:  Radiol Cardiothorac Imaging       Date:  2020-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.